Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pyrocarbon Clinical Follow-up Study

NCT: NCT05049993 · ACTIVE_NOT_RECRUITING

NCT IDNCT05049993
StatusACTIVE_NOT_RECRUITING
Start Date2021-10-27
Completion2027-12-31
SponsorStryker Trauma and Extremities (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this multi-center study is to collect medium and long-term data on the related clinical complications and functional outcomes of the Pyrocarbon Humeral Head to demonstrate safety and performance, in subjects from the Pyrocarbon IDE Study cohort. Data collected from this study will support post-market surveillance and MDR requirements as well provide the basis for peer-reviewed publications on mid- and long-term product performance and safety (five to ten years post-op).

Frequently Asked Questions

What is Pyrocarbon Clinical Follow-up Study?

Pyrocarbon Clinical Follow-up Study is a clinical trial registered under NCT05049993. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05049993?

The current status of NCT05049993 (Pyrocarbon Clinical Follow-up Study) is: ACTIVE_NOT_RECRUITING.

When did Pyrocarbon Clinical Follow-up Study start?

Pyrocarbon Clinical Follow-up Study started on 2021-10-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.